RG
SLN

Rathbones Group’s Silence Therapeutics SLN Stock Holding History

Rathbones Group’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,421
Closed -$107K – 662
2025
Q2 		$107K Hold
18,421
– – ﹤0.01% 583
2025
Q1 		$51.9K Hold
18,421
– – ﹤0.01% 579
2024
Q4 		$127K Hold
18,421
– – ﹤0.01% 559
2024
Q3 		$335K Hold
18,421
– – ﹤0.01% 462
2024
Q2 		$350K Sell
18,421
-1,485
-7% -$31.6K ﹤0.01% 463
2024
Q1 		$430K Buy
+19,906
New +$433K ﹤0.01% 434

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $186M AUM 35.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CF
Cantor Fitzgerald New York $2.76B AUM 29.01% 1-Year Est. Return